• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Intersect ENT, Inc. (Amendment)

    10/8/21 6:18:03 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care
    Get the next $XENT alert in real time by email
    SC 13G/A 1 d193876dsc13ga.txt SC 13G/A SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Intersect ENT, Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------------------------------- (Title of Class of Securities) 46071F103 ------------------------------------------ (CUSIP Number) 9/30/2021 ------------------------------------------ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 46071F103 13G -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Artisan Partners Limited Partnership -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions) (a) [_] (b) [_] Not Applicable -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------------- 5 SOLE VOTING POWER None NUMBER OF SHARES BENEFICIALLY --------------------------- OWNED BY 6 SHARED VOTING POWER EACH 1,219,869 REPORTING --------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH None --------------------------- 8 SHARED DISPOSITIVE POWER 1,454,164 -------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,454,164 -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see Instructions) [_] Not Applicable -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.4% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (see Instructions) IA CUSIP No. 46071F103 13G -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Artisan Investments GP LLC -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions) (a) [_] (b) [_] Not Applicable -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------------- 5 SOLE VOTING POWER None NUMBER OF SHARES BENEFICIALLY --------------------------- OWNED BY 6 SHARED VOTING POWER EACH 1,219,869 REPORTING --------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH None --------------------------- 8 SHARED DISPOSITIVE POWER 1,454,164 -------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,454,164 -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see Instructions) [_] Not Applicable -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.4% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (see Instructions) HC CUSIP No. 46071F103 13G -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Artisan Partners Holdings LP -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions) (a) [_] (b) [_] Not Applicable -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------------- 5 SOLE VOTING POWER None NUMBER OF SHARES BENEFICIALLY --------------------------- OWNED BY 6 SHARED VOTING POWER EACH 1,219,869 REPORTING --------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH None --------------------------- 8 SHARED DISPOSITIVE POWER 1,454,164 -------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,454,164 -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see Instructions) [_] Not Applicable -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.4% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (see Instructions) HC CUSIP No. 46071F103 13G -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Artisan Partners Asset Management Inc. -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions) (a) [_] (b) [_] Not Applicable -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------------- 5 SOLE VOTING POWER None NUMBER OF SHARES BENEFICIALLY --------------------------- OWNED BY 6 SHARED VOTING POWER EACH 1,219,869 REPORTING --------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH None --------------------------- 8 SHARED DISPOSITIVE POWER 1,454,164 -------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,454,164 -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see Instructions) [_] Not Applicable -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.4% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (see Instructions) HC CUSIP No. 46071F103 13G -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Artisan Partners Funds, Inc. -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see Instructions) (a) [_] (b) [_] Not Applicable -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Wisconsin -------------------------------------------------------------------------------- 5 SOLE VOTING POWER None NUMBER OF SHARES BENEFICIALLY --------------------------- OWNED BY 6 SHARED VOTING POWER EACH 987,330 REPORTING --------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH None --------------------------- 8 SHARED DISPOSITIVE POWER 987,330 -------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 987,330 -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see Instructions) [_] Not Applicable -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.0% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (see Instructions) IC Item 1(a) Name of Issuer: Intersect ENT, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 1555 Adams Drive, Menlo Park, CA 94025 Item 2(a) Name of Person Filing: Artisan Partners Limited Partnership ("APLP") Artisan Investments GP LLC ("Artisan Investments") Artisan Partners Holdings LP ("Artisan Holdings") Artisan Partners Asset Management Inc. ("APAM") Artisan Partners Funds, Inc. ("Artisan Funds") Item 2(b) Address of Principal Business Office: APLP, Artisan Investments, Artisan Holdings, APAM, and Artisan Funds are all located at: 875 East Wisconsin Avenue, Suite 800 Milwaukee, WI 53202 Item 2(c) Citizenship: APLP is a Delaware limited partnership Artisan Investments is a Delaware limited liability company Artisan Holdings is a Delaware limited partnership APAM is a Delaware corporation Artisan Funds is a Wisconsin corporation Item 2(d) Title of Class of Securities: Common Stock Item 2(e) CUSIP Number: 46071F103 Item 3 Type of Person: (d) Artisan Funds is an Investment Company under section 8 of the Investment Company Act. (e) APLP is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. (g) Artisan Holdings is the sole limited partner of APLP and the sole member of Artisan Investments; Artisan Investments is the general partner of APLP; APAM is the general partner of Artisan Holdings. Item 4 Ownership (at 9/30/2021): (a) Amount owned "beneficially" within the meaning of rule 13d-3: 1,454,164 (b) Percent of class: 4.4% (based on 33,420,243 shares outstanding as of 9/03/2021) (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: None (ii) shared power to vote or to direct the vote: 1,219,869 (iii) sole power to dispose or to direct the disposition of: None (iv) shared power to dispose or to direct the disposition of: 1,454,164 Item 5 Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6 Ownership of More than Five Percent on Behalf of Another Person: Not Applicable Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person: Not Applicable Item 8 Identification and Classification of Members of the Group: Not Applicable Item 9 Notice of Dissolution of Group: Not Applicable Item 10 Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: 10/8/2021 ARTISAN PARTNERS ASSET MANAGEMENT INC, for itself and as the general partner of ARTISAN PARTNERS HOLDINGS LP By: Gregory K. Ramirez * ------------------------------- ARTISAN INVESTMENTS GP LLC, for itself and as the general partner of ARTISAN PARTNERS LIMITED PARTNERSHIP By: Gregory K. Ramirez * ------------------------------- ARTISAN PARTNERS FUNDS, INC. By: Gregory K. Ramirez * ------------------------------- *By: /s/ Gregory K. Ramirez ------------------------------- Gregory K. Ramirez Executive Vice President of Artisan Partners Asset Management Inc. Vice President of Artisan Investments GP LLC President and Chief Executive Officer of Artisan Partners Funds, Inc. Exhibit Index Exhibit 1 Joint Filing Agreement dated 10/8/2021 by and among Artisan Partners Limited Partnership, Artisan Investments GP LLC, Artisan Partners Holdings LP, Artisan Partners Asset Management Inc., and Artisan Partners Funds, Inc. EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Schedule 13G to which this Agreement is attached. Dated: 10/8/2021 ARTISAN PARTNERS ASSET MANAGEMENT INC, for itself and as the general partner of ARTISAN PARTNERS HOLDINGS LP By: Gregory K. Ramirez * ------------------------------- ARTISAN INVESTMENTS GP LLC, for itself and as the general partner of ARTISAN PARTNERS LIMITED PARTNERSHIP By: Gregory K. Ramirez * ------------------------------- ARTISAN PARTNERS FUNDS, INC. By: Gregory K. Ramirez * ------------------------------- *By: /s/ Gregory K. Ramirez ------------------------------- Gregory K. Ramirez Executive Vice President of Artisan Partners Asset Management Inc. Vice President of Artisan Investments GP LLC President and Chief Executive Officer of Artisan Partners Funds, Inc.
    Get the next $XENT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XENT

    DatePrice TargetRatingAnalyst
    8/12/2021$28.25Outperform → Market Perform
    SVB Leerink
    8/10/2021Buy → Neutral
    BTIG
    8/9/2021$29.00 → $28.25Buy → Hold
    Canaccord Genuity
    8/9/2021$28.25Buy → Neutral
    Guggenheim
    6/24/2021$21.00 → $23.00Market Perform → Outperform
    SVB Leerink
    More analyst ratings

    $XENT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SINUVA issued to INTERSECT ENT INC

    Submission status for INTERSECT ENT INC's drug SINUVA (SUPPL-6) with active ingredient MOMETASONE FUROATE has changed to 'Approval' on 01/20/2023. Application Category: NDA, Application Number: 209310, Application Classification: Labeling

    1/23/23 11:02:41 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    $XENT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intersect ENT downgraded by SVB Leerink with a new price target

    SVB Leerink downgraded Intersect ENT from Outperform to Market Perform and set a new price target of $28.25

    8/12/21 4:49:01 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    Intersect ENT downgraded by BTIG

    BTIG downgraded Intersect ENT from Buy to Neutral

    8/10/21 5:09:28 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    Intersect ENT downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Intersect ENT from Buy to Hold and set a new price target of $28.25 from $29.00 previously

    8/9/21 10:22:16 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    $XENT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hattangadi Neil A

    4 - Intersect ENT, Inc. (0001271214) (Issuer)

    5/16/22 6:58:08 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Meier Richard A closing all direct ownership in the company

    4 - Intersect ENT, Inc. (0001271214) (Issuer)

    5/16/22 6:43:33 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Fernandez Reyna M closing all direct ownership in the company

    4 - Intersect ENT, Inc. (0001271214) (Issuer)

    5/16/22 6:41:18 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    $XENT
    SEC Filings

    View All

    SEC Form POSASR filed by Intersect ENT Inc.

    POSASR - Intersect ENT, Inc. (0001271214) (Filer)

    9/12/22 5:25:28 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    SEC Form RW WD filed by Intersect ENT Inc.

    RW WD - Intersect ENT, Inc. (0001271214) (Filer)

    9/12/22 1:10:59 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12B filed by Intersect ENT Inc.

    15-12B - Intersect ENT, Inc. (0001271214) (Filer)

    5/23/22 6:08:00 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    $XENT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nalu Medical, Inc. Names Thomas West President and Chief Executive Officer

    Current President and CEO, Earl Fender, announces retirement CARLSBAD, Calif., July 14, 2022 /PRNewswire-PRWeb/ -- Nalu Medical, Inc. ("Nalu"), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced today that the Board of Directors has appointed Thomas "Tom" West as President and Chief Executive Officer. This leadership appointment is effective on August 8th and follows the decision by Earl Fender, Nalu's current CEO, to retire. Mr. Fender will remain as a consultant to the company for the next 12 months. Mr. West remarked, "I am very excited and honored to be leading Nalu. I believe Nalu's unique system and technology, including the

    7/14/22 12:05:00 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    Real-World Evidence Study Demonstrates Intersect ENT's PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

    Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative period of 18 months, including all-cause otolaryngologist, ER/urgent care and outpatient visits, as well as sinus-related endoscopies Intersect ENT®, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today announced positive results of an observational, cohort study using real-world evidence (RWE) data from adult patients with chronic rhinosinusitis (CRS) with or without nasal polyps

    1/25/22 7:00:00 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    Orthofix Announces Appointment of Thomas A. West to Board of Directors

    Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company's Board of Directors and appointed to the Compensation and Talent Development Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211214005343/en/Thomas A. West named to Orthofix Board of Directors and appointed to the Compensation and Talent Development Committee. (Photo: Business Wire) Mr. West currently serves as the President, Chief Executive Officer and Director of Intersect ENT, Inc. (NASDAQ:XENT), a commercial stage drug-device company that pioneers

    12/14/21 7:00:00 AM ET
    $OFIX
    $XENT
    Medical/Dental Instruments
    Health Care

    $XENT
    Leadership Updates

    Live Leadership Updates

    View All

    Orthofix Announces Appointment of Thomas A. West to Board of Directors

    Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company's Board of Directors and appointed to the Compensation and Talent Development Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211214005343/en/Thomas A. West named to Orthofix Board of Directors and appointed to the Compensation and Talent Development Committee. (Photo: Business Wire) Mr. West currently serves as the President, Chief Executive Officer and Director of Intersect ENT, Inc. (NASDAQ:XENT), a commercial stage drug-device company that pioneers

    12/14/21 7:00:00 AM ET
    $OFIX
    $XENT
    Medical/Dental Instruments
    Health Care

    Intersect ENT Announces Appointment of New Vice President of Sales

    Mark L. Alley to serve as Vice President of Sales Intersect ENT, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today announced the appointment of Mark L. Alley as Vice President of Sales, effective May 10, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210504005421/en/Mark L. Alley (Photo: Business Wire) Mr. Alley previously served as Chief Commercial Officer at medical device specialist Levita Magnetics Corp. He is a proven leader with over 20 years of commercial and sales success in companies ranging in size from start-ups to Fortune 500 compan

    5/4/21 7:00:00 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    $XENT
    Financials

    Live finance-specific insights

    View All

    Intersect ENT Reports Third Quarter 2021 Financial Results

    Intersect ENT, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended September 30, 2021. Total revenue was $24.4 million for the third quarter of 2021, up 7%, compared to $22.7 million for the same period of 2020. Gross profit for the third quarter of 2021 was $19.3 million and gross margin was 79.2%, compared to gross profit of $14.9 million and gross margin of 65.5% for the same period of 2020. Excluding the impact of intangible asset amortization, adjusted gross profit and adjusted gross margin for the third quarter of 2021 was $19.8 million and 81.2%, resp

    11/2/21 4:15:00 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    Intersect ENT Reports Second Quarter 2021 Financial Results

    Intersect ENT, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today reported financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Overview Entered into a definitive agreement with Medtronic, in which Medtronic will acquire all outstanding shares of Intersect ENT. Revenue of $27.3 million in the second quarter of 2021, up 180%, compared to $9.8 million in the second quarter of 2020. Record quarterly SINUVA revenue of $2.7 million. Global Navigation and Balloon portfolio generated quarterly revenue of $1.6 million. Cash, cash equivalents, restricted cash, and short-term investm

    8/6/21 7:15:00 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    Intersect ENT to Report Second Quarter 2021 Financial Results on August 6

    Intersect ENT, Inc. (NASDAQ:XENT), a global ear, nose and throat ("ENT") medical technology leader dedicated to transforming patient care, today announced that it will release second quarter 2021 financial results on Friday, August 6, 2021. The Company expects to issue the release at approximately 7:00 a.m. ET and management will host a conference call at 8:30 a.m. ET. To access the conference call via the Internet, go to the "Investor Relations" page of the Company's website at www.intersectENT.com. To access the live conference call via phone, dial 844-850-0548 and ask to join the Intersect ENT call. International callers may access the live call by dialing 412-317-5205. Participants may

    7/23/21 8:00:00 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    $XENT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Intersect ENT Inc. (Amendment)

    SC 13G/A - Intersect ENT, Inc. (0001271214) (Subject)

    2/23/22 8:56:48 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Intersect ENT Inc. (Amendment)

    SC 13G/A - Intersect ENT, Inc. (0001271214) (Subject)

    2/17/22 11:40:20 AM ET
    $XENT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Intersect ENT Inc. (Amendment)

    SC 13G/A - Intersect ENT, Inc. (0001271214) (Subject)

    2/14/22 4:41:22 PM ET
    $XENT
    Medical/Dental Instruments
    Health Care